J. Mann

发表

A Systematic Review of Animal Models of NAFLD Finds High‐Fat, High‐Fructose Diets Most Closely Resemble Human NAFLD

I. Rowe, M. Utukuri, Y. R. Im, 2021, Hepatology.

A systematic analysis of rodent models implicates adipogenesis and innate immunity in pathogenesis of fatty liver disease

I. Rowe, M. Utukuri, Y. R. Im, 2020, bioRxiv.

The global prevalence of Wilson disease from next-generation sequencing data

J. Mann, Jiali Gao, S. Brackley, 2018, Genetics in medicine : official journal of the American College of Medical Genetics.

Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management.

M. Armstrong, P. Newsome, E. Koushiappi, 2014, QJM : monthly journal of the Association of Physicians.

Clinical outcomes in pediatric intestinal failure: a meta-analysis and meta-regression

M. Zilbauer, J. Mann, J. Wilkinson, 2019, The American journal of clinical nutrition.

rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

Nicholette D. Palmer, C. Datz, F. Lammert, 2020, Journal of hepatology.

The pharmacological management of NAFLD in children and adolescents

V. Nobili, J. Mann, ROBERT P. Williams, 2017, Expert review of clinical pharmacology.

Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms

J. Hengstler, Trevor A. Mori, A. Alisi, 2022, Hepatology communications.

Insights into paediatric non‐alcoholic fatty liver disease from genetic variants

Y. R. Im, Jiawen Dong, J. Mann, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Comparison of the lipidomic signature of fatty liver in children and adults: a cross-sectional study

A. Alisi, S. Snowden, A. Koulman, 2022, Journal of pediatric gastroenterology and nutrition.

Plasma lipidomics identifies a signature of 1 NAFLD in children that couples with 2 cardiometabolic outcomes in adults. 3

A. Alisi, S. Snowden, A. Koulman, 2021 .

The global prevalence of Wilson disease from next-generation sequencing data

J. Mann, Jiali Gao, S. Brackley, 2018, Genetics in medicine : official journal of the American College of Medical Genetics.

Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients

J. Hodson, Y. Oo, J. Ngu, 2016, Hepatology International.

Animal protein intake and hepatic steatosis in the elderly

J. Mann, G. Tang, 2018, Gut.

Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors

S. Chandran, H. Uppal, R. Potluri, 2019, PloS one.

Update on lipid species and paediatric nonalcoholic fatty liver disease

A. Feldstein, V. Nobili, J. Mann, 2016, Current opinion in clinical nutrition and metabolic care.

Fructose, uric acid, and zonal differences in NASH.

M. Armstrong, M. Armstrong, J. Mann, 2017, Journal of hepatology.

Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease

M. Raponi, A. Alisi, M. Armstrong, 2016, Hepatology.

Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy

J. Hodson, D. Adams, A. Lohse, 2016, Scandinavian journal of gastroenterology.

NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD

Q. Anstee, J. Mann, 2017, Nature Reviews Gastroenterology &Hepatology.

A minority of somatically mutated genes in pre‐existing fatty liver disease have prognostic importance in the development of NAFLD

M. Hoare, J. Mann, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.

L. Baur, A. Alisi, P. Vajro, 2021, The lancet. Gastroenterology & hepatology.

Paediatric NAFLD: more than just small adults.

J. Mann, 2018, The lancet. Gastroenterology & hepatology.

The Clinical Relevance of Differentiating Nonalcoholic Steatohepatitis From Simple Steatosis.

J. Mann, Anna Carter, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Management and outcomes of neonates with down syndrome admitted to neonatal units.

N. Modi, J. Mann, A. Springett, 2016, Birth defects research. Part A, Clinical and molecular teratology.

Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver

I. Rowe, M. Utukuri, Y. R. Im, 2020, eLife.

The global prevalence of Wilson disease from next-generation sequencing data

J. Mann, Jiali Gao, S. Brackley, 2018, Genetics in Medicine.

How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?

M. Armstrong, R. Semple, J. Mann, 2016, Front. Endocrinol..

What lipodystrophies teach us about the metabolic syndrome.

D. Savage, J. Mann, 2019, The Journal of clinical investigation.

Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?

V. Nobili, J. Mann, T. Alterio, 2018, Expert review of gastroenterology & hepatology.

The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.

J. Mann, Jiali Gao, S. Brackley, 2019, Journal of hepatology.

Nonalcoholic Fatty Liver Disease in Children

C. Byrne, V. Nobili, E. Scorletti, 2018, Seminars in Liver Disease.

Sclerosing Cholangitis in Pediatric Inflammatory Bowel Disease - Early Diagnosis and Management Affect Clinical Outcome.

G. Mieli-Vergani, N. Hadžić, M. Gasparetto, 2021, The Journal of pediatrics.

Clinical implications of understanding the association between oxidative stress and pediatric NAFLD

M. Raponi, V. Nobili, J. Mann, 2017, Expert review of gastroenterology & hepatology.

Insights into genetic variants associated with NASH-fibrosis from metabolite profiling

E. Fauman, N. Wareham, M. Allison, 2020, Human molecular genetics.

Somatically mutated genes in fatty liver disease have minimal influence on germline risk

M. Hoare, J. Mann, 2021, medRxiv.

Variants in MARC1 and HSD17B13 reduce severity of NAFLD in children, perturb phospholipid metabolism, and suppress fibrotic pathways

J. Hengstler, A. Alisi, S. Snowden, 2020, medRxiv.

rs641738C>T near MBOAT7 promotes steatosis, NASH, fibrosis and hepatocellular carcinoma in non-alcoholic fatty liver disease: a meta-analysis

Nicholette D. Palmer, C. Datz, F. Lammert, 2020 .

rs641738C>T near MBOAT7 is positively associated with liver fat, ALT, and histological severity of NAFLD: a meta-analysis

Nicholette D. Palmer, C. Datz, F. Lammert, 2019 .

Co-morbidities and mortality associated with intracranial bleeds and ischaemic stroke

A. Aziz, H. Uppal, R. Potluri, 2015, The International journal of neuroscience.

An AGTR1 Variant Worsens Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome.

Dana de Gracia Hahn, A. Duret, J. Mann, 2019, The American journal of gastroenterology.

What influences treatment response in animal models of non-alcoholic fatty liver disease? A meta-analysis with meta-regression

I. Rowe, M. Utukuri, Y. R. Im, 2019, bioRxiv.

Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists

P. McKiernan, J. Mann, R. Goonetilleke, 2015, Archives of Disease in Childhood.

Plasma lipidomics distinguishes NASH and fibrosis from simple fatty liver in children

A. Alisi, S. Snowden, A. Koulman, 2020, medRxiv.

Lipid droplets as the genetic nexus of fatty liver

S. Romeo, Luca Valenti, J. Mann, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.

J. Mann, E. Nassif, J. Krikorian, 1985, Cancer treatment reports.

European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale.

S. O’Rahilly, D. Savage, P. Socha, 2018, Contemporary clinical trials.

What does epilepsy tell us about the neural correlates of consciousness?

A. Cavanna, J. Mann, 2011, The Journal of neuropsychiatry and clinical neurosciences.

Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review.

M. Armstrong, V. Nobili, J. Mann, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

G12 : The burden of cardiovascular disease and mortality across a spectrum of non-alcoholic fatty liver disease: A 14-year follow-up population study of 929,465 individuals

P. Newsome, S. Chandran, H. Uppal, 2015 .

The burden of cardiovascular disease amongst psychiatric patients.

R. Heun, A. Aziz, H. Uppal, 2013, International journal of cardiology.

Diagnosis of fatty liver in children should occur in parallel to investigation for other causes of liver disease.

P. Newsome, A. Alisi, A. Krag, 2023, The lancet. Gastroenterology & hepatology.

Nonalcoholic Fatty Liver Disease in Children.

L. N. Valenti, V. Nobili, C. Byrne, 2018 .

Nonalcoholic Fatty Liver Disease in Children

L. N. Valenti, V. Nobili, C. Byrne, 2018 .

Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives.

M. Buti, T. Karlsen, J. Lazarus, 2023, Journal of hepatology.